Ceftaroline fosamil
- Generic Name
- Ceftaroline fosamil
- Brand Names
- Teflaro, Zinforo
- Drug Type
- Small Molecule
- Chemical Formula
- C22H21N8O8PS4
- CAS Number
- 229016-73-3
- Unique Ingredient Identifier
- 7P6FQA5D21
- Background
Ceftaroline fosamil is a cephalosporin antibacterial indicated for the treatment of the following infections caused by designated susceptible bacteria:
Acute bacterial skin and skin structure infections.
Community-acquired bacterial pneumonia.
- Indication
Ceftaroline fosamil is indicated for the treatment of patients with the following infections caused by susceptible isolates of the designated microorganisms.
- Associated Conditions
- Acute Bacterial Skin and Skin Structure Infection (ABSSSI), Community-Acquired Bacterial Pneumonia (CABP)
- Associated Therapies
- -
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
- Conditions
- Interventions
- First Posted Date
- 2012-02-01
- Last Posted Date
- 2016-04-12
- Lead Sponsor
- Gary E. Stein, Pharm.D.
- Target Recruit Count
- 12
- Registration Number
- NCT01524302
- Locations
- 🇺🇸
Sparrow Hospital, Lansing, Michigan, United States
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
- Conditions
- Interventions
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2017-09-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 802
- Registration Number
- NCT01499277
- Locations
- 🇺🇦
Research Site, Odesa, Ukraine
Ceftaroline China Pharmacokinetics Study
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2017-09-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT01458743
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections
- Conditions
- Interventions
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2015-01-13
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 163
- Registration Number
- NCT01400867
- Locations
- 🇺🇸
Investigational Site - Morgantown, Morgantown, West Virginia, United States
🇬🇪Investigational Site - Tbilisi 2, Tbilisi, Georgia
🇵🇱Investigational Site - Bydgoszcz 2, Bydgoszcz, Poland
A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
- Conditions
- Interventions
- First Posted Date
- 2011-06-13
- Last Posted Date
- 2017-09-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 848
- Registration Number
- NCT01371838
- Locations
- 🇻🇳
Research Site, Hochiminh, Vietnam
Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital
- First Posted Date
- 2011-02-18
- Last Posted Date
- 2014-05-14
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 53
- Registration Number
- NCT01298843
- Locations
- 🇺🇸
Investigational site, Toledo, Ohio, United States
🇺🇸Investigational Site, Morgantown, West Virginia, United States
A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers
- Conditions
- Interventions
- First Posted Date
- 2011-02-07
- Last Posted Date
- 2017-09-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 54
- Registration Number
- NCT01290900
- Locations
- 🇺🇸
Research Site, Overland Park, Kansas, United States
Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age
- First Posted Date
- 2008-03-11
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 9
- Registration Number
- NCT00633126
- Locations
- 🇺🇸
Investigational Site, Durham, North Carolina, United States
🇺🇸Investigational site, Akron, Ohio, United States
🇺🇸Invetigational Site, Cleveland, Ohio, United States
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
- Conditions
- Interventions
- First Posted Date
- 2008-03-11
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 150
- Registration Number
- NCT00633152
- Locations
- 🇺🇸
Investigational Site, Toledo, Ohio, United States
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
- Conditions
- Interventions
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 698
- Registration Number
- NCT00424190
- Locations
- 🇺🇦
Investigational Site, Lviv, Ukraine
🇵🇪Invetigational Site, Lima, Peru
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.